Rachel K. King - 10 Jun 2023 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
Director
Signature
/s/ John A. Herrmann III, Attorney-in-Fact
Issuer symbol
NVAX
Transactions as of
10 Jun 2023
Net transactions value
$0
Form type
4
Filing time
13 Jun 2023, 16:46:05 UTC
Previous filing
22 May 2023
Next filing
03 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise +3,100 +45% 10,050 10 Jun 2023 Direct F1
holding NVAX Common Stock 1,100 10 Jun 2023 See Footnote F2
holding NVAX Common Stock 1,100 10 Jun 2023 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -3,100 -100% $0.000000* 0 10 Jun 2023 Common Stock 3,100 Direct F1, F3
transaction NVAX Stock Option (Right to Buy) Award $0 +7,710 $0.000000 7,710 12 Jun 2023 Common Stock 7,710 $7.78 Direct F4
transaction NVAX Restricted Stock Units Award $0 +6,670 $0.000000 6,670 12 Jun 2023 Common Stock 6,670 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2 Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.
F3 One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date.
F4 One hundred percent (100%) of the shares subject to this option grant under the Plan will vest one (1) year from the June 12, 2023 grant date (the "Grant Date") subject to continued service on the Company's Board of Directors through the vesting date.
F5 One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date.